Nanoencapsulation
Formulation work intended to support controlled handling of target compounds and future delivery research.
Delivery & formulation
Precision formulation for targeted biological engagement.
Formulation and delivery are treated as part of the therapeutic design—not simply as the final packaging step.
Formulation strategy
Designed around interaction, timing and balance.
Leysin’s working thesis is that carefully constructed combinations may be able to engage multiple biological pathways in a more coordinated way than a single isolated target.
The team describes this as a “symphony” of receptor activation coupled with targeted neurotransmitter release, with the broader goal of studying how exogenous compounds interact with endogenous signalling systems.
Research concept, not a therapeutic claim
The biological effects and clinical relevance of any future formulation must be established through appropriate research and regulatory pathways.
FORMULATION
Receptor
targets
targets
Endogenous
signalling
signalling
Release
profiles
profiles
Delivery
timing
timing
Delivery research
Multiple routes, one design philosophy.
The client has identified patent-pending nanoencapsulation-based formulations and intranasal delivery as areas of focus. Technical details remain subject to IP and research review.
Intranasal delivery
A focused research route for studying rapid delivery and potential nose-to-brain transport characteristics.
Target engagement
Programme design informed by receptor pharmacology, neuroplasticity and broader signalling interactions.
A useful mental model
“Single notes” describe narrow interactions. Leysin’s research direction is interested in how carefully composed combinations might act more like a coordinated orchestra.
This language reflects a conceptual framework used by the research team to organise compound complexity and receptor breadth. It is not a clinical classification.
The people behind the work